SCLX · NASDAQ · Drug Manufacturers - General

Scilex

Commercializes non-opioid treatments for acute and chronic pain.

$5.43
After-hours close−0.01 (−0.18%)
At close$5.44(−2.33%)

Breakdown13F · Form 4

Institutions 8.28%Insiders

Shares outstanding 8.49M · Float 7.50M · 88.3% free float

Insiders — no current Form 4 position.

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Scilex Holding Co · 10 percent owner244.45MForm 4Dec 30, 2025
SCLX Stock Acquisition JV LLC · 10 percent owner958.3KForm 4Jul 7, 2026
Oramed Pharmaceuticals Inc.732.7K9.90%13GMay 8, 2025
Vanguard Capital Management LLC301.3K3.55%13FAug 13, 2026
BlackRock, Inc.109.4K1.29%13FAug 7, 2026

Institutions13F, as of Jun 30, 2026

70 holders · 702.8K shares · 12 new positions · 24 increased · 7 reduced · 12 closed

HolderShares% outstandingChg q/qFiled
Vanguard Capital Management LLC301.3K3.55%+37.2KAug 13, 2026
BlackRock, Inc.109.4K1.29%+6.6KAug 7, 2026
Vanguard Fiduciary Trust Co45.8K0.54%+6.2KAug 13, 2026
Jacobs Levy Equity Management, Inc41.2K0.48%+41.2KnewAug 14, 2026
State Street Corp35.4K0.42%0Aug 7, 2026
UBS Group AG33.4K0.39%+26.9KAug 13, 2026
Renaissance Technologies LLC33.1K0.39%−3.8KAug 13, 2026
Citadel Advisors LLC27.5K0.32%+27.5KnewAug 14, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
SCLX Stock Acquisition JV LLC21.10%13DJan 23, 2025
Oramed Pharmaceuticals Inc.9.90%732.7K13GMay 8, 2025

InsidersForm 4

InsiderRoleSharesFiled
Scilex Holding Co10 percent owner244.45MDec 30, 2025
SCLX Stock Acquisition JV LLC10 percent owner958.3KJul 7, 2026

4 ten-percent owners hold 245.55M shares by Form 4 — the 13D/G table above shows those stakes, the figure above counts officers and directors only · 10 people have not refiled in the last 18 months (21.7K shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Apr 17, 2026
Henry Jidirector, officer: Exec Chair, CEO and President
Sale650,000$1.202,600,000
Apr 16, 2026
Henry Jidirector, officer: Exec Chair, CEO and President
Purchase3,250,000$1.203,250,000
Apr 17, 2026
Stephen Hoi Madirector, officer: CFO, COO and Secretary
Purchase650,000$1.20650,000
Dec 30, 2025
Scilex Holding Co10 percent owner
Sale9,657,300$0.5394244,445,260
Dec 29, 2025
Scilex Holding Co10 percent owner
Sale7,310,984$0.6555254,102,560
Dec 26, 2025
Scilex Holding Co10 percent owner
Sale3,689,016$0.7509261,413,544

CongressHouse and Senate disclosures

Not reported.